EntrepreneurialCheck
Mitchell Angove estimated net worth profile

Mitchell Angove net worth

Mitchell Angove Net Worth 2026 (Estimated) · Founder at Feanix Biotechnologies · YC S23
est. wealth $6.67M

Quick answer

Mitchell Angove's estimated net worth is $6.67M (range $4.67M – $10.0M) as of 2026. Mitchell Angove is Founder at Feanix Biotechnologies. Feanix Biotechnologies valuation.

Mitchell Angove is Founder at Feanix Biotechnologies (YC S23). Independent Entrepreneurial Check model estimate from public YC data.

At a glance

NameMitchell Angove
RoleFounder
CompanyFeanix Biotechnologies
YC batchS23
Est. company val$20.0M
Assumed ownership33.3%
Est. paper wealth / net worth$6.67M
$4.67M – $10.0M
  • Company status: Active
  • Region: United States of America
  • Industries: Industrials, Agriculture
  • Team size: 5
  • Website: https://www.feanixbio.com/

Who is Mitchell Angove?

Mitchell Angove is a co-founder of Feanix Biotechnologies, where he focuses on innovative solutions in biotechnology.

About Feanix Biotechnologies

Feanix is a trailblazing force in the trillion-dollar animal breeding industry. Feanix leverages proprietary genetic testing advancements to provide genetics and breeding as a service.

FAQ: Mitchell Angove net worth and Feanix Biotechnologies valuation

What is Mitchell Angove's net worth?

Mitchell Angove's estimated net worth is $6.67M (range $4.67M – $10.0M) as of 2026. Mitchell Angove is Founder at Feanix Biotechnologies. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.

What is Feanix Biotechnologies valuation?

Feanix Biotechnologies's estimated valuation on Entrepreneurial Check is $20.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.

What is Mitchell Angove's role?

Mitchell Angove is Founder at Feanix Biotechnologies, a Y Combinator-backed startup (batch S23).